5α

5α - Names and Identifiers

Name	Stigmastane-3β,5α,6β-triol
Synonyms	5α 6β-triol Stigmastane-3β Stigmastane-3,5,6-triol Stigmastane-3β,5α,6β-triol Stigmastane-3,5,6-triol, (3β,5α,6β)- Stigmastane-3beta,5alpha,6beta-triol 5 alpha-stigmastane-3 beta,5,6 beta-triol 3-monobenzoate
CAS	20835-91-0

5α - Physico-chemical Properties

Molecular Formula	C29H52O3
Molar Mass	448.72
Melting Point	250-252℃
Specific Rotation(α)	0 (CHCl3).?2.9 (Py)
Storage Condition	2-8℃

5α - Introduction

Stigmastane-3β,5α,6β-triol, also known as genistein, is a natural compound that belongs to the class of sterols. Its chemical structure has a 4 ring and a 3β,5α,6β hydroxyl group. The compound can be extracted from some plants.

Stigmastane-3β,5α,6β-triol has multiple effects in terms of biological activity. It was found to have the ability to lower cholesterol and antioxidant activity. In addition, it has anti-inflammatory and anti-tumor activity.

In Terms of Use, Stigmastane-3β,5α,6β-triol is widely used in the field of drug research and development. Due to its regulatory effect on cholesterol, it may be used as a pharmaceutical ingredient for the treatment of related diseases. In addition, it can also be used in food and health product formulations to improve the nutritional value and efficacy of the product.

The method of preparing Stigmastane-3β,5α,6β-triol is obtained by extracting from plants. First, a plant extract containing the compound is extracted from the plant, and then the target compound is obtained through a series of chemical separation and purification steps.

Regarding safety information, Stigmastane-3β,5α,6β-triol is considered to be relatively safe in general dosage, and no definite toxicity has been reported. However, as a pharmaceutical ingredient, it still needs to be used in an appropriate dose and mode of use, and follow the requirements of relevant drug safety evaluation. When using or studying the compound, it is necessary to follow the corresponding laboratory practice and evaluate the safety and potential risks according to the individual's specific situation.

Last Update：2024-04-09 21:01:54